This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MARCUS RAYNER CARO, M.D.

Arch Derm Syphilol. 1949;60(6):1077-1089.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WE ARE living in the "Golden Age" of dermatologic therapy, or so it would seem. During the decade since sulfanilamide was first introduced into therapy a procession of new potent drugs has been added to our weapons against disease. With the sulfonamide compounds in all their many variations; with penicillin, streptomycin, tyrothricin, bacitracin, aureomycin and other antibiotics yet to be named; with the vitamins in all their fractionations; with radioactive isotopes, and with the host of antihistaminic drugs it would seem that the therapeutic progress in these few years is unmatched in any period in history. Only time and the merciless inroads of experience will tell whether these contributions will live through the ages as permanent achievements, as have the artistic wonders of the "Golden Age of Pericles."

It is unfortunate that all these drugs have appeared on the scene as "wonder drugs." Such an introductory appraisal is not conducive . . . [Full Text PDF of this Article]

Author Affiliations
CHICAGO

Footnotes
Read at the Seventh Annual Meeting of the American Academy of Dermatology and Syphilology, Chicago, Dec. 9, 1948.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?